0001145549-20-074058.txt : 20201208 0001145549-20-074058.hdr.sgml : 20201208 20201208170457 ACCESSION NUMBER: 0001145549-20-074058 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201208 DATE AS OF CHANGE: 20201208 EFFECTIVENESS DATE: 20201208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONCORDE FUNDS INC CENTRAL INDEX KEY: 0000822519 IRS NUMBER: 000000000 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05339 FILM NUMBER: 201376035 BUSINESS ADDRESS: STREET 1: 8383 PRESTON CENTER PLAZA DR., STREET 2: SUITE 360 CITY: DALLAS STATE: TX ZIP: 75225 BUSINESS PHONE: 972-701-5400 MAIL ADDRESS: STREET 1: 8383 PRESTON CENTER PLAZA DR., STREET 2: SUITE 360 CITY: DALLAS STATE: TX ZIP: 75225 FORMER COMPANY: FORMER CONFORMED NAME: CONCORDE VALUE FUND INC DATE OF NAME CHANGE: 19920703 0000822519 S000054433 Concorde Wealth Management Fund C000170957 Concorde Wealth Management Fund CONWX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000822519 XXXXXXXX false false false N-1A true Concorde Funds Inc 811-05339 0000822519 549300M1O7ZH5YKQ4R17 8383 Preston Center Plaza Drive Suite 360 Dallas 75225 US-TX US 972-701-5400 U.S. Bancorp Fund Services, LLC 615 East Michigan Street Milwaukee 53202 8336121912 Books and records related to transfer agency, fund accounting and fund administration services provided U.S. Bank National Association 1555 North River Center Drive Suite 302 Milwaukee 53202 8336121912 Books and records related to the custody of Fund assets N N N N-1A 1 N William Marcy N/A N Harold Schneider N/A N Gary B. Wood N/A Y Gregory B. Wood N/A 8383 Preston Center Plaza Suite 360 Dallas 75225 XXXXXX N N N N N N N N Brad A. Kinder CPA 000641 N/A N N N N N N N Concorde Wealth Management Fund S000054433 549300QGXVTXG3GLUU87 N 1 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) N N N N Concorde Financial Corp. 801-16625 000105237 N/A N U.S. Bancorp Fund Services, LLC 85-11357 N/A N N N Intercontinental Exchange Inc 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC N/A N N N Capital Institutional Services Inc 008-22273 000007551 54930061X8RDWFDJIS05 2847.000000000000 Cowen and Company LLC 008-22522 000007616 549300WR155U7DVMIW58 8928.000000000000 Cowen Execution Services LLC 008-46838 000035693 5493005RJDJD18OPUP27 220.000000000000 11995.000000000000 Capital Institutional Services Inc 008-22273 000007551 54930061X8RDWFDJIS05 821183.000000000000 Cowen & Company LLC 008-22522 000007616 549300WR155U7DVMIW58 400734.000000000000 Bank of America N.A. 008-69787 000283942 549300HN4UKV1E2R3U73 1085039.000000000000 J.P. Morgan Chase 008-35008 000000079 ZBUT11V806EZRVTWT807 554435.000000000000 Nomura Trust and Banking Co. Ltd. 008-15255 000004297 OXTKY6Q8X53C9ILVV871 673149.000000000000 U.S. Bank N.A. 008-35359 000017868 H85Z6XZP8B10ES0M2G89 1547219.000000000000 5081759.000000000000 Y 25485753.000000000000 N N N N true INTERNAL CONTROL RPT 2 internalcontrolreport.htm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Shareholders and 

Board of Directors of 

Concorde Funds, Inc. 

  

In planning and performing our audit of the financial statements of Concorde Wealth Management Fund, a series of Concorde Funds, Inc. (Company) as of and for the year ended September 30, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Company’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. The management of the Company is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements. 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. 

Our consideration of the Company’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Company’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of September 30, 2020. 

This report is intended solely for the information and use of management and the Board of Directors of Concorde Funds, Inc. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/Brad A. Kinder, CPA 

  

BRAD A. KINDER, CPA 

  

Flower Mound, Texas 

November 23, 2020